NCT01969916

Brief Summary

Our hypothesis is that quantitative 3D analysis of cardiac CT images obtained during vasodilator stress can accurately identify patients presenting at the emergency department with acute chest pain due to underlying hemodynamically significant coronary stenosis, aid in the identification of individuals most likely to benefit from revascularization, and thus improve the ability to predict patient outcomes. Our goals are:

  1. 1.to test the above hypothesis by comparing stress MDCT perfusion data with invasive fractional flow reserve (FFR) data in patients with significant stenosis who undergo ICA;
  2. 2.to determine the added value of MDCT perfusion as an adjunct to CTCA for predicting patient outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 25, 2013

Completed
7 months until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
9 months until next milestone

Results Posted

Study results publicly available

February 18, 2019

Completed
Last Updated

February 21, 2021

Status Verified

February 1, 2021

Enrollment Period

4 years

First QC Date

October 21, 2013

Results QC Date

November 12, 2018

Last Update Submit

February 17, 2021

Conditions

Keywords

Cardiac CT imagingMyocardial ischemiaMyocardial perfusionVasodilator stress testingRegadenoson

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Detected Stress-induced Perfusion Abnormalities by 3D Analysis of MDCT Images

    Perfusion defect on stress CT images obtained at peak effect of Regadenoson, in the presence of coronary stenosis \>50%.

    At least 1 year

Study Arms (1)

Regadenoson

OTHER
Drug: Regadenoson

Interventions

Patients will be given a single dose of Lexiscan (0.4 mg, iv bolus)

Also known as: Lexiscan
Regadenoson

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with chest pain referred for CT coronary angiography

You may not qualify if:

  • allergy to iodine,
  • renal dysfunction (creatinine \>1.6 mg/dL)
  • chronic obstructive pulmonary disease
  • advanced heart block
  • or systolic blood pressure \<90 mmHg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medical Center

Chicago, Illinois, 60637, United States

Location

Related Publications (12)

  • Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002 Jan 29;105(4):539-42. doi: 10.1161/hc0402.102975. No abstract available.

    PMID: 11815441BACKGROUND
  • Corsi C, Lang RM, Veronesi F, Weinert L, Caiani EG, MacEneaney P, Lamberti C, Mor-Avi V. Volumetric quantification of global and regional left ventricular function from real-time three-dimensional echocardiographic images. Circulation. 2005 Aug 23;112(8):1161-70. doi: 10.1161/CIRCULATIONAHA.104.513689. Epub 2005 Aug 15.

    PMID: 16103242BACKGROUND
  • de Roos A. Myocardial perfusion imaging with multidetector CT: beyond lumenography. Radiology. 2010 Feb;254(2):321-3. doi: 10.1148/radiol.09092106. No abstract available.

    PMID: 20093505BACKGROUND
  • Deetjen AG, Conradi G, Mollmann S, Ekinci O, Weber M, Nef H, Mollmann H, Hamm CW, Dill T. Diagnostic value of the 16-detector row multislice spiral computed tomography for the detection of coronary artery stenosis in comparison to invasive coronary angiography. Clin Cardiol. 2007 Mar;30(3):118-23. doi: 10.1002/clc.20059.

    PMID: 17385719BACKGROUND
  • Garcia MJ, Lessick J, Hoffmann MH; CATSCAN Study Investigators. Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis. JAMA. 2006 Jul 26;296(4):403-11. doi: 10.1001/jama.296.4.403.

    PMID: 16868298BACKGROUND
  • Hulten EA, Bittencourt MS, Ghoshhajra B, Blankstein R. Stress CT perfusion: coupling coronary anatomy with physiology. J Nucl Cardiol. 2012 Jun;19(3):588-600. doi: 10.1007/s12350-012-9546-5.

    PMID: 22456969BACKGROUND
  • Kachenoura N, Veronesi F, Lodato JA, Corsi C, Mehta R, Newby B, Lang RM, Mor-Avi V. Volumetric quantification of myocardial perfusion using analysis of multi-detector computed tomography 3D datasets: comparison with nuclear perfusion imaging. Eur Radiol. 2010 Feb;20(2):337-47. doi: 10.1007/s00330-009-1552-x. Epub 2009 Aug 27.

    PMID: 19711083BACKGROUND
  • Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JA. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008 Nov 27;359(22):2324-36. doi: 10.1056/NEJMoa0806576.

    PMID: 19038879BACKGROUND
  • Mor-Avi V, Lodato JA, Kachenoura N, Chandra S, Freed BH, Newby B, Lang RM, Patel AR. Quantitative three-dimensional evaluation of myocardial perfusion during regadenoson stress using multidetector computed tomography. J Comput Assist Tomogr. 2012 Jul-Aug;36(4):443-9. doi: 10.1097/RCT.0b013e31825833a3.

    PMID: 22805675BACKGROUND
  • Patel AR, Lodato JA, Chandra S, Kachenoura N, Ahmad H, Freed BH, Newby B, Lang RM, Mor-Avi V. Detection of myocardial perfusion abnormalities using ultra-low radiation dose regadenoson stress multidetector computed tomography. J Cardiovasc Comput Tomogr. 2011 Jul-Aug;5(4):247-54. doi: 10.1016/j.jcct.2011.06.004. Epub 2011 Jun 12.

    PMID: 21723516BACKGROUND
  • Schroeder S, Achenbach S, Bengel F, Burgstahler C, Cademartiri F, de Feyter P, George R, Kaufmann P, Kopp AF, Knuuti J, Ropers D, Schuijf J, Tops LF, Bax JJ; Working Group Nuclear Cardiology and Cardiac CT; European Society of Cardiology; European Council of Nuclear Cardiology. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J. 2008 Feb;29(4):531-56. doi: 10.1093/eurheartj/ehm544. Epub 2007 Dec 15.

    PMID: 18084017BACKGROUND
  • Techasith T, Cury RC. Stress myocardial CT perfusion: an update and future perspective. JACC Cardiovasc Imaging. 2011 Aug;4(8):905-16. doi: 10.1016/j.jcmg.2011.04.017.

    PMID: 21835384BACKGROUND

MeSH Terms

Conditions

Coronary Artery DiseaseMyocardial Ischemia

Interventions

regadenoson

Condition Hierarchy (Ancestors)

Coronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Limitations and Caveats

The main limitation of quantitative analysis of myocardial perfusion from CT images is that it is prone to artifacts caused by beam hardening, which mimic perfusion defects.

Results Point of Contact

Title
Victor Mor-Avi
Organization
University of Chicago

Study Officials

  • Victor Mor-Avi, Ph.D.

    University of Chicago

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2013

First Posted

October 25, 2013

Study Start

June 1, 2014

Primary Completion

June 1, 2018

Study Completion

June 1, 2018

Last Updated

February 21, 2021

Results First Posted

February 18, 2019

Record last verified: 2021-02

Locations